Brief: Sequana Medical Reports FDA Acceptance For Substantive Review Of Premarket Approval Application For Alfapump

Sequana Medical NV

29/01/2024 06:01

Jan 29 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES FDA ACCEPTANCE FOR SUBSTANTIVE
REVIEW
OF THE PREMARKET APPROVAL APPLICATION FOR ALFAPUMP® IN RECURRENT
OR REFRACTORY ASCITES DUE TO LIVER CIRRHOSIS

Source text for Eikon:  ID:nGNXbFsWhh 
Further company coverage:  SEQUA.BR 

 ((Reuters.Briefs@thomsonreuters.com;))